← Back to headlines
Biotech Shares Surge Following Positive Clinical Trial Announcements
Shares of several biotechnology firms rallied after announcing successful clinical trial outcomes, including Pharvaris’s late-stage hereditary angioedema study and Roivant’s Phase 2 results. The positive data also highlighted progress in aging research from Genflow Biosciences.
8 Sept, 10:50 — 8 Sept, 13:29
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (47/100)4 sources30/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center3
Center (3)
morningstarinvesting-comtaiwan-news
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 2 regions9/34
US3Taiwan1
Sources
Showing 4 of 4 sources
morningstar1d ago
Genflow Biosciences reports positive anti-ageing dog trial results - Morningstar
Genflow Biosciences reports positive anti-ageing dog trial results Morningstar
Read full article →seeking-alphaMixed1d ago
Pharvaris rises on late-stage trial win for hereditary angioedema drug
Read full article →investing-com1d ago
Pharvaris stock surges 27% on positive trial data
By Investing.com
Read full article →taiwan-newsMostly Factual1d ago
Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks - Taiwan News
Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks Taiwan News
Read full article →Coverage Timeline
First report: taiwan-news · 8 Sept, 10:50|Full coverage: 4 · 3h|Window: 3h
Left-leaningCenterRight-leaning
Related Stories
European Natural Gas Prices Surge Past €80 Amid Middle East Tensions
21m ago
Google Announces $15 Billion AI Infrastructure Investment in Finland
46m ago
EU Proposes Stricter Rules for Short-Term Rentals and Public Procurement
55m ago
Jersey Mike's Reports 2.3% Same-Store Sales Growth, Targets 2.5-3% by 2026
1h ago